Amrutanjan Health Care Q1 Results
- BSE: 590006
- NSE: AMRUTANJAN
- ISIN: INE098F01031
- Sector: Biotechnology & Drugs
BSE
502
-4.25 (-0.84%)
-4.25 (-0.84%)Volume1.75 K
Updated: Mon 7 Sep, 2026 | 15:08:47
NSE
498.70-6.75 (-1.34%)
-6.75 (-1.34%)Volume55.01 K
Updated: Mon 7 Sep, 2026 | 14:53:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹102.97 Cr.(9.49%)
- Operating Profit₹2.30 Cr.(-66.77%)
- Profit After Tax₹4.37 Cr.(-47.47%)
- Operating Margin2.23%(-69.65%)
Note: Comparison is on YoY basis
Quarterly - Amrutanjan Health Care Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 100.67 | 133.44 | -24.56% | 81.77 | 15.54% |
| Depreciation/ Amortization | 1.92 | 1.61 | 19.24% | 1.59 | 25.12% |
| Operating Income | 2.30 | 16.33 | -85.93% | 1.96 | -66.77% |
| Net Income | 4.37 | 16.19 | -73.04% | 4.62 | -47.47% |
| Other Operating Expenses Total | 17.01 | 17.47 | -2.65% | 13.55 | 32.63% |
| Net Income Before Taxes | 6.07 | 21.02 | -71.12% | 6.35 | -46.25% |
| Total Revenue | 102.97 | 149.77 | -31.25% | 83.74 | 9.49% |
| Selling/ General/ Admin Expenses Total | 25.44 | 33.23 | -23.45% | 22.63 | 8.79% |
| Diluted Normalized EPS | 2.01 | 7.63 | -73.60% | 1.60 | -29.81% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.